Cvs Health Corp Stock Current Valuation

CVS Stock

USD 59.96 0.95 1.61%

Valuation analysis of CVS Health Corp helps investors to measure CVS Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to gain to about 91.1 B in 2024, whereas Enterprise Value Over EBITDA is likely to drop 7.58 in 2024. Fundamental drivers impacting CVS Health's valuation include:

Price Book

0.9909

Enterprise Value

147.3 B

Enterprise Value Ebitda

10.3713

Price Sales

0.2022

Forward PE

9.3897

Undervalued

Today

59.96

Please note that CVS Health's price fluctuation is very steady at this time. Calculation of the real value of CVS Health Corp is based on 3 months time horizon. Increasing CVS Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.

Buy or Sell Advice Valuation Matrix

The fair value of the CVS stock is determined by what a typical buyer is willing to pay for full or partial control of CVS Health Corp. Since CVS Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CVS Stock. However, CVS Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.

Historical

Market 59.96

Real 75.06

Target 90.16

Hype 59.99

Naive 60.67

The intrinsic value of CVS Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CVS Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.

53.96

Downside

75.06

Real Value

Target Odds

Above Odds

Below Odds

77.64

Upside

Estimating the potential upside or downside of CVS Health Corp helps investors to forecast how CVS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CVS Health more accurately as focusing exclusively on CVS Health's fundamentals will not take into account other important factors:

Earnings

Estimates (0)

Low	Projected	High
1.17	1.33	1.46

Details

Hype

Prediction

Low	Estimated	High
57.41	59.99	62.57

Details

Potential

Annual Dividend

Low	Forecasted	High
1.74	1.90	2.05

Details

28 Analysts

Consensus

Low	Target Price	High
82.05	90.16	100.08

Details

CVS Health Corp Company Current Valuation Analysis

CVS Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current CVS Health Current Valuation

147.28 B

Most of CVS Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS Health Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

CVS Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for CVS Health is extremely important. It helps to project a fair market value of CVS Stock properly, considering its historical fundamentals such as Current Valuation. Since CVS Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CVS Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CVS Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Good Will	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		0.97	0.97	0.91	0.94	1.0	0.98	0.83	0.95	0.94	0.96	0.99	0.95	-0.58	0.57	0.58	0.97	0.19	0.87	0.79	0.62	0.67	0.81	0.96	0.96	-0.82	0.72
Total Stockholder Equity	0.97		0.89	0.94	0.93	0.94	0.97	0.78	0.9	0.94	0.89	0.96	0.87	-0.6	0.53	0.66	0.91	0.24	0.77	0.78	0.53	0.61	0.8	0.88	0.9	-0.81	0.72
Net Debt	0.97	0.89		0.83	0.85	0.98	0.91	0.84	0.98	0.84	0.96	0.97	0.98	-0.55	0.65	0.53	0.95	-0.01	0.93	0.75	0.75	0.73	0.69	0.97	0.93	-0.73	0.6
Retained Earnings	0.91	0.94	0.83		0.95	0.89	0.96	0.8	0.82	0.99	0.78	0.92	0.82	-0.79	0.46	0.66	0.81	0.31	0.69	0.88	0.38	0.67	0.77	0.77	0.79	-0.78	0.73
Net Receivables	0.94	0.93	0.85	0.95		0.93	0.98	0.75	0.82	0.97	0.87	0.94	0.83	-0.58	0.4	0.66	0.9	0.46	0.7	0.86	0.37	0.58	0.92	0.85	0.87	-0.9	0.88
Total Liab	1.0	0.94	0.98	0.89	0.93		0.97	0.83	0.95	0.92	0.97	0.99	0.96	-0.56	0.57	0.55	0.97	0.17	0.89	0.79	0.64	0.68	0.81	0.97	0.96	-0.81	0.71
Total Current Assets	0.98	0.97	0.91	0.96	0.98	0.97		0.8	0.88	0.98	0.91	0.97	0.89	-0.64	0.49	0.6	0.93	0.32	0.78	0.83	0.48	0.63	0.86	0.89	0.91	-0.84	0.78
Short Term Debt	0.83	0.78	0.84	0.8	0.75	0.83	0.8		0.76	0.78	0.76	0.8	0.75	-0.6	0.55	0.55	0.78	-0.03	0.71	0.69	0.48	0.95	0.57	0.77	0.78	-0.73	0.52
Intangible Assets	0.95	0.9	0.98	0.82	0.82	0.95	0.88	0.76		0.81	0.93	0.96	0.99	-0.58	0.62	0.55	0.91	-0.07	0.94	0.73	0.79	0.66	0.62	0.94	0.89	-0.64	0.53
Accounts Payable	0.94	0.94	0.84	0.99	0.97	0.92	0.98	0.78	0.81		0.83	0.93	0.83	-0.71	0.46	0.59	0.86	0.4	0.71	0.86	0.36	0.62	0.85	0.81	0.84	-0.82	0.79
Common Stock	0.96	0.89	0.96	0.78	0.87	0.97	0.91	0.76	0.93	0.83		0.95	0.94	-0.39	0.52	0.45	0.99	0.15	0.89	0.68	0.66	0.6	0.8	1.0	0.99	-0.78	0.68
Good Will	0.99	0.96	0.97	0.92	0.94	0.99	0.97	0.8	0.96	0.93	0.95		0.96	-0.6	0.56	0.61	0.95	0.17	0.87	0.82	0.63	0.66	0.79	0.95	0.93	-0.79	0.71
Long Term Debt	0.95	0.87	0.98	0.82	0.83	0.96	0.89	0.75	0.99	0.83	0.94	0.96		-0.58	0.61	0.5	0.92	-0.03	0.95	0.75	0.77	0.65	0.65	0.95	0.9	-0.65	0.56
Treasury Stock	-0.58	-0.6	-0.55	-0.79	-0.58	-0.56	-0.64	-0.6	-0.58	-0.71	-0.39	-0.6	-0.58		-0.44	-0.39	-0.39	0.02	-0.53	-0.74	-0.26	-0.61	-0.26	-0.38	-0.39	0.28	-0.24
Property Plant Equipment	0.57	0.53	0.65	0.46	0.4	0.57	0.49	0.55	0.62	0.46	0.52	0.56	0.61	-0.44		0.27	0.46	-0.24	0.65	0.46	0.57	0.47	0.21	0.54	0.49	-0.28	0.1
Current Deferred Revenue	0.58	0.66	0.53	0.66	0.66	0.55	0.6	0.55	0.55	0.59	0.45	0.61	0.5	-0.39	0.27		0.51	0.13	0.33	0.65	0.34	0.47	0.51	0.48	0.45	-0.7	0.58
Short Term Investments	0.97	0.91	0.95	0.81	0.9	0.97	0.93	0.78	0.91	0.86	0.99	0.95	0.92	-0.39	0.46	0.51		0.2	0.85	0.71	0.62	0.62	0.84	0.99	0.99	-0.84	0.74
Net Tangible Assets	0.19	0.24	-0.01	0.31	0.46	0.17	0.32	-0.03	-0.07	0.4	0.15	0.17	-0.03	0.02	-0.24	0.13	0.2		-0.18	0.26	-0.54	-0.22	0.68	0.09	0.18	-0.49	0.7
Long Term Debt Total	0.87	0.77	0.93	0.69	0.7	0.89	0.78	0.71	0.94	0.71	0.89	0.87	0.95	-0.53	0.65	0.33	0.85	-0.18		0.71	0.79	0.63	0.51	0.91	0.87	-0.52	0.34
Capital Surpluse	0.79	0.78	0.75	0.88	0.86	0.79	0.83	0.69	0.73	0.86	0.68	0.82	0.75	-0.74	0.46	0.65	0.71	0.26	0.71		0.32	0.6	0.67	0.69	0.7	-0.71	0.57
Deferred Long Term Liab	0.62	0.53	0.75	0.38	0.37	0.64	0.48	0.48	0.79	0.36	0.66	0.63	0.77	-0.26	0.57	0.34	0.62	-0.54	0.79	0.32		0.45	0.18	0.7	0.61	-0.27	0.11
Short Long Term Debt	0.67	0.61	0.73	0.67	0.58	0.68	0.63	0.95	0.66	0.62	0.6	0.66	0.65	-0.61	0.47	0.47	0.62	-0.22	0.63	0.6	0.45		0.35	0.62	0.62	-0.55	0.33
Cash And Equivalents	0.81	0.8	0.69	0.77	0.92	0.81	0.86	0.57	0.62	0.85	0.8	0.79	0.65	-0.26	0.21	0.51	0.84	0.68	0.51	0.67	0.18	0.35		0.77	0.82	-0.93	0.94
Net Invested Capital	0.96	0.88	0.97	0.77	0.85	0.97	0.89	0.77	0.94	0.81	1.0	0.95	0.95	-0.38	0.54	0.48	0.99	0.09	0.91	0.69	0.7	0.62	0.77		0.98	-0.78	0.65
Long Term Investments	0.96	0.9	0.93	0.79	0.87	0.96	0.91	0.78	0.89	0.84	0.99	0.93	0.9	-0.39	0.49	0.45	0.99	0.18	0.87	0.7	0.61	0.62	0.82	0.98		-0.82	0.68
Net Working Capital	-0.82	-0.81	-0.73	-0.78	-0.9	-0.81	-0.84	-0.73	-0.64	-0.82	-0.78	-0.79	-0.65	0.28	-0.28	-0.7	-0.84	-0.49	-0.52	-0.71	-0.27	-0.55	-0.93	-0.78	-0.82		-0.89
Capital Stock	0.72	0.72	0.6	0.73	0.88	0.71	0.78	0.52	0.53	0.79	0.68	0.71	0.56	-0.24	0.1	0.58	0.74	0.7	0.34	0.57	0.11	0.33	0.94	0.65	0.68	-0.89

Click cells to compare fundamentals

CVS Current Valuation Historical Pattern

Today, most investors in CVS Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CVS Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CVS Health current valuation as a starting point in their analysis.

CVS Health Current Valuation

Timeline

Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Competition

Predict CVS Health

Enterprise Value Over Time

In accordance with the recently published financial statements, CVS Health Corp has a Current Valuation of 147.28 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is significantly lower than that of the firm.

CVS Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CVS Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CVS Health could also be used in its relative valuation, which is a method of valuing CVS Health by comparing valuation metrics of similar companies.

CVS Health is currently under evaluation in current valuation category among its peers.

CVS Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CVS Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CVS Health's managers, analysts, and investors.

Environmental

Governance

Social

CVS Fundamentals

	Return On Equity	0.067
	Return On Asset	0.0237
	Profit Margin	0.01 %
	Operating Margin	0.02 %
	Current Valuation	147.28 B
	Shares Outstanding	1.26 B
	Shares Owned By Insiders	0.11 %
	Shares Owned By Institutions	82.91 %
	Number Of Shares Shorted	21.85 M
	Price To Earning	42.99 X
	Price To Book	0.99 X
	Price To Sales	0.20 X
	Revenue	357.78 B
	Gross Profit	53.46 B
	EBITDA	13.74 B
	Net Income	8.37 B
	Cash And Equivalents	12.95 B
	Cash Per Share	15.21 X
	Total Debt	79.39 B
	Debt To Equity	1.00 %
	Current Ratio	0.94 X
	Book Value Per Share	59.57 X
	Cash Flow From Operations	13.43 B
	Short Ratio	1.65 X
	Earnings Per Share	3.94 X
	Price To Earnings To Growth	2.23 X
	Target Price	68.35
	Number Of Employees	219 K
	Beta	0.54
	Market Capitalization	74.26 B
	Total Asset	249.73 B
	Retained Earnings	61.6 B
	Working Capital	(11.33 B)
	Current Asset	30.38 B
	Current Liabilities	23.17 B
	Annual Yield	0.05 %
	Five Year Return	2.81 %
	Net Asset	249.73 B
	Last Dividend Paid	2.6

About CVS Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CVS Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVS Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVS Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for CVS Stock Analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cvs Health Corp Stock Current Valuation

CVS Health Corp Company Current Valuation Analysis

Enterprise Value

Market Cap + Debt

-

Cash

Current CVS Health Current Valuation

CVS Current Valuation Driver Correlations

CVS Current Valuation Historical Pattern

CVS Current Valuation Peer Comparison

CVS Health ESG Sustainability

CVS Fundamentals

About CVS Health Fundamental Analysis

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for CVS Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY